Scientific Calendar Event
GO TO SCIENTIFIC CALENDAR



  • Europe/Rome
  • English
  • Administration

Search

Search in Conferences:

Support

Home > Author Index

Author List

Displaying 30 authors out of 30
A. CAVALLI (Univ. of Bologna, Dept. of Pharmaceutical Sciences, Bologna, Italy)
Multifunctional strategies in the search for novel lead candidates against Trypanosoma and Leishmania
A. GEE (Clinical Imaging Centre, Imperial College London, U.K.)
PET in Drug Discovery and Development
A. GIORGETTI, S. PANTANO AND E. IPPOLITI (Univ.Verona, Biotechnologie, Italy/ Inst.Pasteur Montevideo, Uruguay/ SISSA, Trieste, Italy)
Presentation of SISSA's Bioinformatics Laboratory, where on the 6th and 7th of June, participants taking part in the Training Course (week 8-12 June) will be working.
A. MARCELLO (ICGEB, Molecular Virology Lab., Padriciano, Trieste, Italy)
Spatial and Temporal Correlates of Viral Replication in Single Cells in Real Time
A. SHARMA PRAKASH (ICGEB, New Delhi, India)
Bio-informatics and Structural Biology Approaches to the Development of Anti-malaria Compounds
B. DE GROOT (Max Planck Inst. for Biophysical Chemistry, Gottingen, Germany)
Flexibility and Drug Design
C.L.M.J. VERLINDE (Biomolecular Structure Centre, Univ. of Washington, Seattle, U.S.A.)
Forces and Energies I
Forces and Energies II
The TDR Drug Target Database
Solvation
Scoring Functions
Docking
Absorption, Distribution, Metabolism, Excretion I
Absorption, Distribution, Metabolism, Excretion II
Design of New Anti-Chagas Therapeutics
E. ARNOLD (CABM and Rutgers Univ., Piscataway, U.S.A.)
Structure-based Design of Drugs and Vaccines for Treatment and Prevention of HIV infection
E. LATTMAN (Hauptman Woodward Medical Research Institute, Buffalo, U.S.A.)
Welcome on behalf of the Organizers
The Art and Science of Protein Structure Determination
H. MITSUYA (NIH/NCI at Bethesda, MD, USA and Kumamoto Univ., Japan)
Development of four anti-AIDS Drugs: Successes and Challenges
I. SIDDIQI (Central Drug Research Institute, Lucknow, India)
Knowledge Based Identification and Prioritization of Potent Anti-tubercolar Compounds Using Structure-based Virtual Screening and Structure Interaction Fingerprints
M. D. WALKINSHAW (Univ. of Edinburgh, Structural Biochemistry, Edinburgh, U.K.)
Immunophilins as Anti-infective Drug Targets
M. LUSIC (ICGEB, Molecular Medicine)
Molecular Mechanisms Regulating HIV-1 Integration and Latency
M.A. PARNIAK (Univ. of Pittsburgh, School of Medicine, U.S.A.)
Developing Successful Microbicides for Blocking HIV Transmission
M.D. WALKINSHAW (Univ. of Edinburgh, Structural Biochemistry, Edinburgh, U.K.)
Glycolytic Targets in Trypanosomatids
N. RAMAMOORTHY (IAEA, Vienna, Austria)
Principles and Scope of Radiotracers and Related Techniques in Drug Development
N. SIVAPRASAD (BRIT, BARC Vashi Complex, Mumbai, India)
Role of Labelled Compounds in Drug Development and Manufacture: Indian experience
N.B. ABD. RAHMAN (Univ. of Malaya, Chemistry, Kuala Lumpur, Malaysia)
Molecular Modelling Study, Design and Development of New Anti-dengue Compounds
P. CARLONI (SISSA, Trieste, Italy)
Organizational Remarks
Molecular Simulation and Drug Design
P. SENECI (Univ. of Milan, Dept. of Organic & Industrial Chemistry, Milan, Italy)
Drug Discovery Using Combinatorial Chemistry Approaches
POSTER SESSION
R. NUSSINOV (NCI at Frederick, Computational Structural Biology Group, Frederick, MD, U.S.A.)
Computational Strategies in Drug Discovery and Design
S. MIERTUS (ICS/UNIDO, Padriciano, Trieste, Italy)
Welcome on behalf of ICS/UNIDO
S. PANTANO (Inst. Pasteur de Montevideo, Uruguay)
Molecular Modeling of New Targets Against AIDS
S. RANDJBAR-DAEMI (Assistant Director)
Welcome on behalf of ICTP
S.H. HUGHES (NIH/NCI at Frederick, MD, U.S.A.)
Biological and Chemical Considerations for the Development of Drugs Targeting HIV-1 Reverse Transcriptase
V. FRECER (ICS/UNIDO, Padriciano, Trieste, Italy)
Computer Drug Design and Computer Assisted Combinatorial Chemistry: Applications for Anti-bird Flu and Anti-HIV Drugs
W.G.J. HOL (Biomolecular Structure Centre, Univ. of Washington, Seattle, WA, U.S.A.)
Modes of Drug Action I
Modes of Drug Action II
Structural biology in Drug Design
Targeting the Malaria Parasite's Invasion Machinery
Modes of Drug Resistance
Multivalent Drugs and Diarrheal Diseases
Structures of M. Tuberculosis Drug Targets
Protein Structures for Drug Design Against Tropical Protozoa
CONCLUDING REMARKS
W.N. HUNTER (Univ. of Dundee, Life Sciences, Dundee, U.K.)
Characterization and Targeting of Trypanosomatid Pteridine Reductase
The Non-mevalonate Pathway of Isoprenoid Biosynthesis; Essential Activities in Apicomplexans and Gram-negative Bacteria
Drug Discovery Research in an Academic Environment

Organizers

W.G.J. Hol, E. Lattman, S. Miertus and P. Carloni (also Local Organizer)